Antibody Response to Breakthrough SARS-CoV-2 Infection in “booster” Vaccinated Patients With Multiple Myeloma According to B T NK Lymphocyte Absolute Counts and Anti-CD38 Treatments. Mediterr J Hematol Infect Dis 2024, 16 (1), e2024022. https://doi.org/10.4084/MJHID.2024.022.